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The blood beryllium lymphocyte proliferation test (BeLPT) is a modification of the standard
lymphocyte proliferation test that is used to identify persons who may have chronic beryllium
disease. A major problem in the interpretation of BeLPT test results is outlying data values among
the replicate well counts (=7%). A log-linear regression model is used to describe the expected
well counts for each set of Be exposure conditions, and the variance of the well counts is
proportional to the square of the expected count. Two outlier-resistant regression methods are
used to estimate stimulation indices (Sls) and the coefficient of variation. The first approach uses
least absolute values (LAV) on the log of the well counts as a method for estimation; the second
approach uses a resistant regression version of maximum quasi-likelihood estimation. A major
advantage of these resistant methods is that they make it unnecessary to identify and delete
outliers. These two new methods for the statistical analysis of the BeLPT data and the current
outlier rejection method are applied to 173 BeLPT assays. We strongly recommend the LAV
method for routine analysis of the BeLPT. Outliers are important when trying to identify individuals
with beryllium hypersensitivity, since these individuals typically have large positive SI values. A
new method for identifying large Sls using combined data from the nonexposed group and the
beryllium workers is proposed. The log(SIl)s are described with a Gaussian distribution with
location and scale parameters estimated using resistant methods. This approach is applied to the
test data and results are compared with those obtained from the current method. Environ
Health Perspect 104(Suppl 5):957-968 (1996)
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Introduction
Chronic beryllium disease (CBD), a disorder one of several criteria for diagnosis of the
that mainly affects the lung, occurs in a disease (1). In vitro proliferation of
small percentage of persons exposed to bronchoalveolar lavage (BAL) cells when
beryllium dusts. Most investigators require exposed to beryllium is extremely sensitive
evidence ofberyllium hypersensitivity as to and specific for the diagnosis of CBD
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but is not suitable for screening since it is
an invasive procedure (1). A noninvasive
procedure based on the proliferative
response of blood cells to beryllium has
been developed and is referred to as the
beryllium-specific lymphocyte proliferation
test (BeLPT)(2). This modification of the
standard lymphocyte-proliferation test is
used to identify relatively rare individuals
among worker cohorts who display delayed
hypersensitivity reactions when exposed to
beryllium metal. The BeLPT involves in
vitro challenge ofperipheral blood lympho-
cytes with salts of beryllium combined
with assays for clonal proliferation ofsensi-
tized subsets of CD4 lymphocytes using
tritiated thymidine uptake as a quantitative
measure of blastogenesis. The test is con-
ducted using 96-well microtiter plates; the
amounts oftritiated thymidine incorporated
by replicate wells containing lymphocytes
challenged with beryllium is compared
with uptake of radioactivity by replicate
wells of nonchallenged lymphocytes to
establish stimulation indices (SIs) as a mea-
sure of in vitro sensitivity to beryllium. A
major problem in the interpretation of
BeLPT test results is outlying data values
( 7%) among the replicate well counts.
The increasing use ofberyllium in several
new economic sectors emphasizes the need
for medical surveillance in the workplace for
CBD (3). In particular, beryllium has been
used in the nuclear industry for a number
of years. Kreiss et al. (4) have examined
the epidemiology of CBD in a stratified
sample of workers at a nuclear weapons
plant and discuss the role ofthe BeLPT in
beryllium disease surveillance in the
nuclear industry. The U.S. Department of
Energy (DOE) is operating a screening pro-
gram for CBD that will eventually include
approximately 15,000 current and former
beryllium-exposed workers at 20 DOE
sites. Each participating beryllium worker
will have a BeLPT at an approved labora-
tory using a standard protocol developed by
the Committee to Accredit Beryllium
Sensitization Testing (CABST). The results
ofeach assay will be evaluated and classified
as normal, abnormal, or unsatisfactory.
A major concern that was not com-
pletely resolved by the CABST was how to
deal with outliers that occur in the BeLPT
data. The main purpose ofthis report is to
propose a new statistical approach that
can be used for analysis of a BeLPT assay
that may contain multiple outlying well
counts. Given their undue influence on the
estimates ofthe SIs. a method for handling
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outliers is needed. The current approach
(as described in the July 1993 version of
the CABST protocol ["Appendix"]) is
based on an ad hoc outlier rejection
method. As an alternative we propose using
resistant estimation methods that are not
sensitive to outliers. The BeLPT assay is
described with a regression model that
relates the expected well counts at each of
the three beryllium concentrations to the
control well counts for cells that are har-
vested after 5 and 7 days. Resistant fitting
methods are used to estimate the SI for
each of the six beryllium concentrations.
The main advantage of this approach is
that estimates of the SIs are calculated
without explicitly identifying and deleting
the outlyingwell counts.
Figure 1. Oak Ridge Institute for Science and
Education BeLPT culture assay. ConA, concanavalin A;
PHA, phytohemagglutinin.
A second question considered is the
identification ofberyllium-exposed workers
who exhibit beryllium hypersensitivity.
Most (over 90%) ofthe beryllium workers
will have SIs similar to those of a control
group with no known exposure to beryl-
lium. However, even after the use of resis-
tant estimation methods to minimize the
effect of outlying well counts, the BeLPT
for some beryllium workers will yield large
SIs. In this case we want to identify the
outliers (i.e., individuals with large SIs),
since they represent beryllium workers who
exhibit beryllium hypersensitivity.
Beryllium Lymphocyte
Proliferation Test
A detailed description of lymphocyte
culture methods, quality control measures,
and examples of plate maps and printouts
of raw data are included in the Appendix.
Following is a briefdescription (Figure 1)
ofthe protocol for the BeLPT culture assay
as established by CABST and implemented
by the BeLPT laboratory at Oak Ridge
Institute for Science and Education
(ORISE) as ofJuly 1993. The details of
this procedure and the equipment used
vary at different laboratories that are
performing the BeLPT.
First, a 15-ml blood sample is obtained
from each patient and mononuclear cells
are separated using density gradient cen-
trifugation. Next, lymphocytes are cultured
using standard methods at a final concen-
tration of 2.5 x 105 cells per well in 96-
well, flat-bottom microtiter plates. For
each BeLPT assay, 12 replicate control
wells and four replicates for each experi-
mental condition (i.e., 1, 10, and 100 pM
of BeSO4, and mitogen-stimulated posi-
tive controls) are set up. Third, cells are
incubated at 37°C for 5 and 7 days and a
Table 1. Well counts for BeLPT assay (AC153 data shown
pulse of tritiated thymidine is delivered
prior to harvest. Cells are harvested on fil-
ter paper and counts are measured in a
Packard Matrix 96 gas ionization counter
(Packard Instrument Co., Downer's Grove,
IL). Each filter is counted for 30 min and
the results organized as shown in Table 1
for statistical analysis.
Statistical Methods
In this section we describe three methods
of analyses for the BeLPT assay. The first
method is the outlier rejection procedure
proposed by CABST. A regression model is
proposed to describe the two new methods,
which are least absolute value (LAV)
regression on the log counts and resistant
maximum quasi-likelihood estimation. The
regression model is motivated by the fact
that the SI describes the relative increases
in the proliferative response of beryllium-
stimulated cells to control cells. This leads
to the log-linear representation of treat-
ment effects. It is also apparent (Results)
that the variability in the well counts
increases approximately in proportion to
the square of the expected count, so that
the coefficient ofvariation (CV) is constant
(i.e., the standard deviation is proportional
to the mean). This implies that taking logs
of the well counts leads to constant vari-
ance and additive effects, and the main
parameters of interest are the log(SI)s. If
there were no problem with outliers, stan-
dard least squares methods could be used
on the transformed data. This approach
was not considered since the occurrence of
multiple outliers has been well established.
FirstMethod, Based on Outlier
Rejection Procedure
At the time this work was initiated, CABST
had proposed a method for calculating SIs
Culture conditions j Replicate counts
Day 5 Control 1 965 1173 828 862
Control 1 1474 7237 1021 976
Control 1 1500 1729 1672 1992
Be 1 2 1050 706 1434 687
Be 10 3 1551 1466 1661 2301
Be 100 4 3571 5780 4011 5229
Day 7 Control 5 9202 5253 3786 5212
Control 5 2310 2844 1915 3102
Control 5 2458 3936 3087 6588
Be 1 6 714 1135 6084 1097
Be 10 7 786 846 2757 652
Be 100 8 6037 8349 6852 10449
Day 5 PHA 9 82425 52954 52669 50487
Candida 10 35501 21623 21551 22087
PHA, phytohemagglutinin.
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I. Culture method
Heparinized blood (-15 ml)
Ficoli-hypaque centrifugation
Separated lymphocytes
RPMI 1640 Medium
10% pooled human serum
antibiotics
11. Beryllium challenge
2.5x105 lymphocytes perwell
96-well, flat-bottomed microtiter plates
Beryllium No. replicate Day of
sulfate (pM) wells harvest
0 12 5,7
1 4 5,7
10 4 5,7
100 4 5,7
PHA(30 pM/ml) 4 5
ConA(10 pM) 4 5
Ill. Harvest method (days 5and 7)
Add tritiated thymidine (-8:00AM)
(1 pCi/well specific activity 5-7 mCi/mMol)
Freeze plates at-200C (-4:00 PM)
Perform 30-min counts on Packard Matrix 96
gas ionization counter
IV. Data reduction
Control wells
12 replicates-drop outliers
calculate mean and CV
Be treatments
4 replicates-drop 1 outlier
calculate mean and CV
Stimulation index =(SI)
mean Be treated SI = mean control
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that used an ad hoc procedure for deleting
outliers based on the value of the CV for
each set ofculture conditions. Ifthe CV is
greater than 0.3, the most extreme count is
deleted. This procedure is continued until
the CV is less than or equal to 0.3, pro-
vided no more than one-third of the well
counts have been deleted. A patient's data
are listed as "acceptable" ifthe resulting CV
is less than 0.3 for both day 5 and day 7
control data, and for at least four ofthe six
sets ofberyllium-stimulated quadruplicates.
Ifthese conditions are not met, the BeLPT
is called "unsatisfactory" due to high vari-
ability in the data. A BeLPT is also consid-
ered unsatisfactory if the positive-control
response is too low (indicating lack ofcell
viability), or if the control counts are con-
sidered to be either too low (relative to
background) or too high. We assume here
that BeLPTs that are unsatisfactory for
either ofthe latter two reasons are identified
before further analysis using criteria that
depend on laboratory experience.
The SIs for the stimulated cells are the
ratios of the treatment means and the
corresponding control means (after the
outliers have been deleted), i.e.,
SI- mean(treated)
mean(control)
The positive control wells are only counted
for 10 min, so the SIs are multiplied by 3
to adjust for the counting-time difference.
The results of applying this procedure to
the BeLPT data in Table 1 are given in
Table 2. These data are acceptable since
both of the control CVs are less than 0.3,
and all six beryllium-stimulated CVs are
less than 0.3. The procedure used to deter-
mine if a BeLPT is abnormal is presented
at the end ofthis section.
RerssionModelforthe BeLPT Data
LetYjk denote the well count for the kth
replicate ofthejth set ofculture conditions.
The expected count in each well is repre-
sented by a log-linear regression function:
E(yjk)
=Aj
=exp(Xj13), [1]
wherej = 1. 0 and k = 12 for the
controls and k = 1,2,3,4 for the beryllium-
stimulated cells and the positive controls.
In Equation 1, X1 is a row vector ofindica-
tor variables and / is the vector of regres-
sion parameters (below). We further
assume that the variance ofthe well counts
is proportional to the square of the In the absence of outliers, ordinary least
expected count: squares on the transformed data would
yield consistent estimates for the log(SI)
parameters (5). The effect of outliers is
Var(Yjk)=(OAj) [2] minimized by using LAV (or some other
robust method) on the zjk. LAV regres-
Equations 1 and 2 together are referred to sion-also known as LI norm, least
as a generalized linear model with constant absolute deviations (LAD), and minimum
coefficient of variation-as detailed by sum of absolute errors (MSAE)-is well
McCullagh and Nelder (5). The distinct known to be resistant to outliers and is an
values ofthe row vectors ofcovariates Xj, important particular case ofa general class
j = 1.10 are shown in Table 3. of robust methods known as M-estimators
With this parameterization, the first (6,7). In general, LAV regression requires
three ,Bs represent the log ofthe SIs for the special computational resources to calculate
three concentrations of BeSO4 on harvest parameter estimates (8). In this situation,
day 5 and the next three Ps are the corre- however, it is only necessary to find the
sponding estimates on day 7. The last two median of the log of the well counts for
B s are the log(SI)s for the positive control each set of design conditions (say Z) and
wells, and 07 and /8 represent the log of then subtract the control median for each
the control well counts on days 5 and 7. harvest day from the beryllium-stimulated
respectively. We have developed two out- medians. Frome et al. present details in
lier-resistant approaches for estimating the Appendices A and C of a report for Oak
SIs and the coefficient ofvariation, 4. Ridge National Laboratory (9). A resistant
estimate ofthe coefficient ofvariation can Se iondMethod, Based on LAV then be obtained as
Regression on Log(y)
The first approach based on the regression = C X medianJ]Z -
model is to take the log ofthe counts since [jk
this is the variance-stabilizing transfor-
mation and leads to a linear model in
zjk = log(yjk), i.e., where C= 1.48 x nl(n-p), n = 56, and
p = 10 (when the assay is complete). The
2 value of Cis chosen to make the estimate
E(zjk) =Xj - and Var(zjk) ~ consistent for the standard deviation for a
2 an
Table 2. Results ofthe current outlier rejection method forTable 1.
Culture conditions n Average CV Si log(SI)
Day 5 Control 10 1220 0.28
Be 1 3 814 0.25 0.67 -0.40
Be 10 4 1744 0.22 1.43 0.36
Be 100 4 4648 0.22 3.81 1.34
Day 7 Control 8 2930 0.24
Be 1 3 982 0.24 0.34 -1.09
Be 10 3 761 0.13 0.26 -1.35
Be 100 4 7921 0.25 2.70 1.00
Day 5 PHA 4 59634 0.25 146.6 4.99
Candida 4 25190 0.27 61.9 4.13
Table 3. Distinct rows in the model matrix.
I Xji %x2 Xj3 Xj4 Xj5 Xj6 Xj7 X18 xjg Xj10
1 0 0 0 0 0 0 1 0 0 0
2 1 0 0 0 0 0 1 0 0 0
3 0 1 0 0 0 0 1 0 0 0
4 0 0 1 0 0 0 1 0 0 0
5 0 0 0 0 0 0 0 1 0 0
6 0 0 0 1 0 0 0 1 0 0
7 0 0 0 0 1 0 0 1 0 0
8 0 0 0 0 0 1 0 1 0 0
9 0 0 0 0 0 0 1 0 1 0
10 0 0 0 0 0 0 1 0 0 1
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Gaussian error model and for consistency
with the usual least squares results, in
which the estimated variance is multiplied
by the correction factor n/(n -p) (10) and
S-PLUS function MAD (11), which com-
putes the median absolute deviation
(MAD) estimate ofthe standard deviation.
Alternative approaches to estimating 4
have been discussed in the context ofLAV
regression (7,12) and there is no consensus
as to the best approach. In addition to the
fact that 4 is of direct interest, it is also
needed to obtain an estimate of the para-
meter covariance matrix
(02(X'X)-l
where ()2 = [2f(0)]2 is the asymptotic
variance of the sample median (13).
Following the approach of McGill et al.
(14) we assume that the underlying error
distribution is Gaussian in the center and
use 6 = ,rI2~P to obtain an estimate ofthe
standard deviation ofthe log ofthe stimu-
lation indices. The appropriate diagonal
term from (X'X)-l is 4/12, and conse-
quently the estimated standard deviation of
log(SI) is 1.25,L(O.58) = 0.72 4OL The
results of applying this approach to the
data in Table 1 are shown in Table 4.
ThirdMethod, Basedon
Quasi-likelihood Estimation
In the second regression model approach,
the analysis is done on the original scale
and estimation is based on an iterative
weighted least squares (IWLS) algorithm.
The use of IWLS for generalized linear
(15) and nonlinear (16) regression func-
tions leads to maximum likelihood esti-
mates when the dependent variable is in
the regular exponential family. McCullagh
(17) extended this result to quasi-likeli-
hood (QL) estimation, which requires
specification of the mean and variance
function. Extension of IWLS to resistant/
robust regression has been described by
Green (18) and Pregibon (19), and the
computational approach described by
Chambers and Hastie (20) is used here.
Similar resistant regression methods have
been applied to the analysis ofdrug concen-
tration-time data encountered in human
bioavailability studies (21).
Consider the following weighted sum
ofsquares,
II jk[Yjk-Ai] i k
until convergence. Frome et al. (9) present
details in their Appendix D. The moment
estimate of 02 is computed after the final
iteration
A 2
02 = Yjk Yjk
n-p Yjk
To adjust for the effect ofoutliers we intro-
duce a secondweight for each observation,
-=f
1 lul<k
W kl lul lul>k [5]
[3]
whereAi = exp(Xj,1) and Wjk a l/var(Yk) =
l/2. The IWLS procedure starts with an
initial estimate, say,B°, and A7 in Equation 3
is replaced with the first orderTaylor series
exp(Xj13') + PjS'
where P = XJ/, and the weights are evalu-
ated at ,6 to obtain
SWkYjk_(AO + pja)
The unknown "correction vector," 60, is
then calculated usingweighted least squares,
i.e. by solving
(P-'WP)j5' =P'W'[Y-K] [4]
for 6'. The estimate of/B is then updated
13l =p+&0, and the procedure is repeated
where u = (Yjk-3jk)I4)ik is the standardized
residual using the current estimates of ,B
and 4. This is known as an M-estimator
with Huber's loss function. The "tuning
constant," k, must be specified and we use
k = 1.345, which leads to estimates with
approximately 95% efficiency (19).
Therefore, to obtain resistant quasi-likeli-
hood estimates we multiply the elements of
the diagonal matrix Win Equation 4 by
the Huber weights discussed in Equation
5; again, details can be found in Appendix
D in Frome et al. (9). Following the last
iteration, an estimate of the coefficient of
variation is obtained using a scaled MAD
estimate of the standardized residuals
Ujk= (Yjk
-Yjk) jk
4 = 1.48xmedian{lujIk} x
n p
IdentificationofBeLPTswithLargeSIs
The CABST method for identifying
an "abnormal" BeLPT is based on the
Table 4. Results of LAV estimation for log(y) of data in Table 1,OiL=0.367.
Experimental conditions Zjk z1 (Zjk- j)I¢L / exp(f)
Day 5 Controls 6.872 7.067 6.719 6.759 7.182 -0.8 -0.3 -1.3 -1.2
Controls 7.296 8.887 6.929 6.883 7.182 0.3 4.6 -0.7 -0.8
Controls 7.313 7.455 7.422 7.597 7.182 0.4 0.7 0.7 1.1
Be 1 6.957 6.560 7.268 6.532 6.758 0.5 -0.5 1.4 -0.6 -0.423 0.655
Be 10 7.347 7.290 7.415 7.741 7.381 -0.1 -0.2 0.1 1.0 0.199 1.221
Be 100 8.181 8.662 8.297 8.562 8.429 -0.7 0.6 -0.4 0.4 1.248 3.483
Day7 Controls 9.127 8.567 8.239 8.559 8.139 2.7 1.2 0.3 1.1
Controls 7.745 7.953 7.557 8.040 8.139 -1.1 -0.5 -1.6 -0.3
Controls 7.807 8.278 8.035 8.793 8.139 -0.9 0.4 -0.3 1.8
Be 1 6.571 7.034 8.713 7.000 7.017 -1.2 0.0 4.6 0.0 -1.122 0.326
Be 10 6.667 6.741 7.922 6.480 6.704 -0.1 0.1 3.3 -0.6 -1.436 0.238
Be 100 8.706 9.030 8.832 9.254 8.931 -0.6 0.3 -0.3 0.9 0.792 2.207
Day 5 PHA 11.320 10.877 10.872 10.829 10.874 1.2 0.0 0.0 -0.1 4.792 120.50
Candida 10.477 9.982 9.978 10.003 9.992 1.3 0.0 0.0 0.0 3.910 49.880
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distribution of the maximum SI for a
group ofindividuals with no known expo-
sure to beryllium. First calculate the maxi-
mum of the estimated SIs (MSI) for each
person in the nonexposed group,
MSI(i) =maX[Slij j = 15...6j i = 1.Ne,
[6]
where NA is the number in the nonexposed
group. The mean and standard deviation
ofthe MSIs are then used to calculate SI* =
mean + 2 (standard deviations). A BeLPT
for a beryllium worker is defined as abnor-
mal ifat least two SIs exceed SI*. Using the
current value (SI* = 5.65), we conclude
that the BeLPT in Table 2 is normal. The
probability of obtaining a statistical false
positive for this procedure is unknown.
We propose an alternative approach that
establishes a reference database ofBeLPTs
based on BeLPTs from nonexposed workers
and historical data from beryllium workers.
The best way to establish this reference data-
base is laboratory dependent and will not be
discussed here. For illustrative purposes we
will use the combined data from the beryl-
lium workers and the nonexposed (control)
group. The method is based on the assump-
tions that the estimates ofthe log(SI)s are
approximately normally distributed and that
almost all ofthe beryllium workers are not
sensitized. Resistant methods are then used
to counter the influence ofoutliers (i.e., the
abnormal test results). The first step is to
calculate an outlier-resistant estimate of
location,ft, and spread, Sr, for each ofthe six
log(SI) distributions in the reference data-
base. In the results that followwe use
j=median(1,1i, i =1.N), and
i =MAD(13,1i =1...,N),
where N=173 andj=1, . . . 6. The second
step is to convert the log(SI)s for each indi-
vidual into standardized deviates
ui.= - [7]
S.
using the values off1 andsL, from the refer-
ence database. The six standardized deviates
for a BeLPT are compared to the zp quan-
tile ofthe standard normal distribution. If
at least two of these values exceed zp, the
BeLPT is called abnormal. Ifthe estimated
log(SI)s are independent, then the bino-
mial distribution can be used to calculate
an approximate probability ofat least kout
of six "large" SIs for a given value of zp.
The probability of at least one large SI
is 1-p6 = 0.141 (forp = 0.975). The proba-
bility ofat least two is 1 - [p6 + 6(1 -p)p5]
= 0.009 (for p = 0.975). In fact, the
log(SI)s are positively correlated, so this
probability should be a lower bound on the
chance offinding a false positive BeLPT.
Results
The regression model and the estimation
methods were obtained through analytic
reasoning and limited experience with a
few data sets. To evaluate the utility ofour
two new methods, we applied them to all
available BeLPT assay results obtained at
the ORISE BeLPT laboratory as ofJuly
1993. The outlier rejection method in use
at ORISE at that time also was applied to
each BeLPT assay.
As a preliminary step we provide an
analysis ofthe 12 replicate control wells on
days 5 and 7 for each ofthe 173 BeLPTs.
Estimates ofscale and location are com-
puted to verify the assumed form of the
mean-variance relation. We then describe
the distribution ofestimates ofthe log(SI)s
for each beryllium concentration. Under the
null assumption that ifan individual is not
sensitized to beryllium his/her SIs should be
one, and the estimates ofthe log(SI)s will be
approximately normally distributed with a
zero mean and the covariance matrix indi-
cated in "Methods." The true SI for an
individual for any given beryllium concen-
tration is, ofcourse, unknown. In a popula-
tion of nonsensitized individuals, the true
log(SI)s may differ from zero. Conse-
quently, the distribution ofestimates ofthe
log(SI)s presented in this 'section reflect
sampling variation, possible differences in
responsiveness among individuals who are
not beryllium sensitized, and the presence
ofberyllium-sensitized workers. As a matter
ofconvenience, we may refer to the distrib-
ution of estimates of the log(SI)s in this
section as a distribution oflog(SI)s.
Description ofthe Data
A total of 173 BeLPTs are used in this
evaluation. There are 133 from a group of
120 workers exposed to beryllium; the
remaining 40 are from persons who have
no known exposure to beryllium. The dis-
crepancy between the number oftest results
and the number of beryllium-exposed
workers is accounted for by the fact that a
second BeLPT was carried out on 13
workers. Ideally, there should be 56 obser-
vations (well counts) for each assay, but in
some cases, well counts are missing due to
insufficient number of cells or technical
errors ("Appendix"). When an assay is
incomplete, parameters are estimated (if
possible), based on the reduced data set.
Comparison ofMomentandResistant
Estimates ofthe Coefficient of
Variationfor ControlWells
An important assumption is that the stan-
dard deviation ofthe well counts is propor-
tional to the mean as implied by Equation
2. Each ofthe 173 assays contains 12 repli-
cate control wells on both days 5 and 7. To
verify this assumption, location and scale
estimates for the control wells for each
assay on days 5 and 7 were calculated.
Figure 2A shows the relationship between
the moment estimator oflocation (y, the
sample mean) and the moment estimator
ofscale (s, the sample standard deviation)
for the day 5 control wells.
The solid line is the least squares fit
s=0.448y, and the slope (0.448) is an esti-
mate ofthe coefficient ofvariation for day
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Figure 2. (A) Relationship between the mean, 7, and
the standard deviation, s, for day 5 control wells. The
solid line indicates the least squares fit, s= 0.448y. 0,
beryllium workers (n=133); A, nonexposed workers
(n=40). (B) Relationship between the median,y, and
the MAD, d. The solid line is the LAVfit, d= 0.34y. The
broken lines indicate the result of applying scatterplot
smoothers tothe data.
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5. Figure 2B is a similar plot using resistant
estimates oflocation and scale. The sample
median (y) replaces the sample mean, the
MAD estimate (6) replaces s, and LAV is
used to regress &ony. The fit is & = 0.34y
and the slope (0.34) is a resistant estimate
ofthe coefficient ofvariation. The decrease
in scatter and slope in Figure 2B reflects
the use ofresistant methods.
Figure 3 shows the relationship between
the resistant estimates oflocation and scale
for the day 5 control wells (Figure 3A) and
the day 7 control wells (Figure 3B) on a
log-log scale. The solid line for day 5 in
Figure 3 (A) is log& = log(O.34) + log(]),
and the solid line for day 7 (Figure 3B) is
logd = log(0.36) + log(f). Note that if& is
proportional toy (i.e., constant coefficient
ofvariation) then the log-log plot should
be linear with a slope ofone. The slope of
the least squares regression of log a on
log(y) for day 5 is 1.04 (standard error =
0.04) and for day 7 the slope is 0.96 (stan-
dard error = 0.03). Since neither estimate is
significantly different from 1, this supports
the regression model assumption of con-
stant coefficient ofvariation. The main dif-
ference in the day 5 and day 7 results is
that the day 7 results are shifted to the
right since the control-well counts are gen-
erally higher on day 7 than those on day 5.
A
5000 6
The median of the ys on day 5 is 1247
compared with 1840 for day 7. These
results are consistent with the laboratory
observation that day 7 results are generally
higher and show greater variability than
well counts on day 5.
SummaryofResults forThe Methods
The three methods ofanalysis were applied
to the data described at the beginning of
this section. For each method, two graphi-
cal displays summarized the results. Only
the results for the LAV method are pre-
sented here since the plots for the other
two methods were very similar in appear-
ance and are available elsewhere (9).
The first graphical display (Figure 4) is
a series of 12 boxplots (11,14,22) placed
side by side for the log(SI)s; the horizontal
axis on the bottom shows the untrans-
formed SIs. The ends of the box corre-
spond to the 25th and 75th percentile so
that 50% of the log(SI)s are contained in
the box for each group. The vertical dotted
lines are drawn to the nearest value not
beyond a standard span-1.5 x (inter-
quartile range)-from the quartiles. The
outlying values are shown individually for
each group ofdata. There are two boxplots
for each beryllium concentration on days 5
and 7. The first one in each pair is labeled
-6 -4 -2
"BW" for beryllium workers, and the sec-
ond one is labeled "NE" for not exposed.
Consequently, each pair of boxplots pro-
vides a comparison of the distribution of
the SIs for the beryllium group and the
nonexposed group for each of the six cul-
ture conditions. Consider, for example, the
first two boxplots in Figure 4 which are for
beryllium concentration 1 on day 5 (BW-
D5Bel and NE-D5BeI) for the LAV esti-
mates. Both log(SI) distributions are
centered near zero and the nonexposed
group is a little more spread out in the cen-
ter. The beryllium-workers group shows
nine outlying values in the positive direc-
tion and one in the negative direction. The
notches (which represent confidence limits
for the sample median) in the boxplots
overlap, indicating that the difference in
the location ofthe two distributions is not
significant at a rough 5% level. The broken
vertical line corresponds to log(SI) equal to
zero and passes through both notches,
indicating that both distributions are cen-
tered near zero on the log scale. Each ofthe
boxplots in Figure 4 is centered near zero
and is spread out evenly in both directions.
As the beryllium concentration increases on
each day the variability (as indicated by the
length ofthe boxes) increases. On day 7 the
SIs for the beryllium workers are generally
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Figure 3. Relationship between the median, y, and the
MAD, Cy (C = 0.34y) for the day 5 (A) and day 7 (B)
control wells (a= 0.361y) shown on a log-log scale.
The broken lines show the results of applying a scat-
terplot smoother to the data. 0, beryllium workers
(n =133); A, nonexposed workers (n =40).
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Figure 4. Boxplots of LAV estimates of the log(SI)s for beryllium workers (BW) and nonexposed (NE) group by day
and beryllium concentration.
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Day 5 Be 1
M= 0.066 exp(M) = 1.07
S= 0.317
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Figure 5. Normal probability plots of LAV log(SI)s. Solid lines in each plot indicates relation expected if log (SI) values are from a normal distribution with location parameter
M(determines intercept) and standard deviation S(determines slope).
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smaller that those for the nonexposed
group, and the median log(SI)s are less
than zero except for the NE-D7Be1OO
group. Results on day 7 are more variable
than those on day 5 for each of the three
beryllium concentrations. We have no
definitive experimental data to explain the
larger variability on day 7. However, con-
sidering that we are conducting short-term
cultures oflymphocytes without replenish-
ing of medium, it is not surprising to
observe greater variability among wells
with increasing time in culture since one
would expect to see some depletion of
nutrients, accumulation of metabolic
byproducts, or scenescence oflymphocyte
over time. In beryllium-sensitive persons,
increasing divergence of counts between
replicate wells would be anticipated to
result from clonal expansion ofsensitized
CD4 subsets which would be expected to
become more pronounced with increasing
numbers ofcell replications.
The second graphical display (Figure 5)
shows a normal (Gaussian) probability plot
for the combined BW and NE SIs for each
of the three beryllium concentrations on
days 5 and 7 (23). In each ofthe six plots,
the data (ordered values ofthe log(SI)s) are
shown on the vertical axis on the left, and
the quantiles ofthe standard normal distri-
bution are shown on the horizontal scale.
Statistical theory indicates that estimates of
the log(SI)s should be approximately nor-
mally distributed, and the large sample
standard deviation should be about 0.28 if
the coefficient of variation is 0.4 (see
"Statistical Methods"). If the relation
between the empirical and theoretical
quantiles is linear, this indicates that the
distribution is Gaussian. In each plot we
have included the median (labeled M) and
a resistant estimate of the standard devia-
tion (labeled S) for the log(SI)s. The solid
line in each plot shows the relation
expected if the log (SI) values are from a
normal distribution with median M(which
determines the intercept) and standard
deviation S (which determines the slope).
(The values of Mand S are also shown in
Table 5). Resistant methods were used to
estimate the location and scale parameters
for the combined data from the BW and
NE groups. This reflects the assumption
that most beryllium workers do not show
an abnormal response, i.e., they look like
the nonexposed group. For example, con-
sider the plot for day 5 Be 1 in Figure 5.
The log(SI)s appear to be approximately
normal in the center. but several values are
larger than expected (these are the points
above the line). These outliers are SIs that
indicate hypersensitivity to beryllium.
The results in Figure 5 indicate that the
log(SI)s are approximately normally dis-
tributed. The center ofeach log(SI) distrib-
ution is greater that zero for each beryllium
concentration on day 5 and is less than
zero for each beryllium concentration on
day 7. The untransformed SI units are
shown on the vertical scale on the right
side ofeach plot. The estimated standard
deviations increase with beryllium concen-
tration on each day, and are larger on day 7
than on day 5. The estimates of location
(,u) and scale (s) for each method are sum-
marized in Table 5. For each beryllium
concentration the estimates from the three
methods are in very close agreement. The
boxplots and normal probability plots for
the current method and the QL method
are not shown here since they are almost
identical to Figures 4 and 5 and are avail-
able elsewhere (9).
Comparison oftheCurrentMethod
andLAVMethod
A direct comparison of estimates of the
log(SI)s obtained using the current
method and the LAV method for each
beryllium concentration is given in Figure
6. The slope of the line in Figure 6 indi-
cates exact agreement between the two
methods. To further compare the current
method and the LAV approach we use the
average difference (avedif) of the log(SI)s.
For each BeLPT the LAV log(SI)s are sub-
tracted from the corresponding log(SI)s
based on the current method. The result is
Table 5. Median estimates (jY) and resistant estimates (I) of the standard deviation (shown in parentheses) of
Iog(SI)s for BeLPT data.
Day 5 Day7
Method Be 1 Be 10 Be 100 Be 1 Be 10 Be 100
Current (Aj) 0.069 0.104 0.280 -0.191 -0.330 -0.163
(1j) (0.300) (0.568) (0.802) (0.514) (0.857) (1.066)
LAV (Aj) 0.066 0.152 0.284 -0.211 -0.388 -0.139
(1j) (0.317) (0.531) (0.770) (0.599) (0.883) (1.113)
QL (Qj) 0.049 0.102 0.258 -0.211 -0.375 -0.226
(1j) (0.337) (0.561) (0.795) (0.665) (0.918) (1.155)
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Figure 6. Comparison ofcurrent outlier rejection method and LAVlogSIl)s for each Be concentration.
Environmental Health Perspectives * Vol 104, Supplement 5 * October 1996 964STATISTICAL METHODS FOR BeLPT
multiplied by 100 and the average difference
is calculated, i.e.
avedif12 = mean[100 * (f3cM - 1.6]
For example, for AC147 (Table 6), the cur-
rent method day 5 BelOO SI is exp(1.41) =
4.10 and exp(1.45) = 4.26 for the LAVpro-
cedure. The log percent (L%) difference is
100 x log(4.10/4.26) = 100 x (1.41 - 1.45)
= - 4L% where L% stands for the logarith-
mic percent (24). The SI for the current
method is 96% of the LAV SI, i.e., about
4% smaller. The average difference between
the current method and LAV method for
AC117 is -1.7L%. Table 6 compares
AC147s log(SI)s for all three methods.
Figure 7 (left panel) shows a boxplot of
avedifl2 (as defined above) for the 173
BeLPTs. The average difference is between
Table 6. Comparison of log (SI)s for patient AC147.a
-3L% and 9L% 50% ofthe time and the
mean of the average difference is 3L%. A
large, positive value of avedifl2 indicates
that the current method log(SI)s for a
BeLPT are greater than the LAV log(SI)s.
The results in Figures 6 and 7 and Table 5
show that the estimates of the log(SI)s for
the LAV and current method are in very
close agreement.
Comparison ofResistantQuasi-
Likelihood Methodand LAVMethod
The plot ( not shown) ofthe QL and LAV
log(SI)s was almost identical to Figure 6.
The close agreement between the two
methods is further demonstrated by the
average difference
avedif32 =
mean[100 *(lBQL -'L0 j = 1.6].
Day 5 Day 7
Method Be 1 Be 10 Be 100 Be 1 Be lOb BelOOb
Current 0.33 1.83 1.41 -0.17 1.86 1.81
LAV 0.26 1.85 1.45 -0.01 1.81 1.81
DL 0.16 1.67 1.39 -0.03 1.72 1.67
100 *- CM-LAV) 7 -2 -4 -16 5 0
100 *(QL -LAV) -10 -18 -6 -2 -9 -14
aDetails presented in Frome et al. (9), Appendix E. bThe last two rows are in L% units.
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Figure 7. Distribution of average difference of log(SI)s.
where a large positive value indicates that
the QL log(SI)s for a BeLPT are greater
than the LAV log(SI)s. Figure 7 (right
panel) shows a boxplot ofthese values. The
average difference is between -6L% and
3L% 50% ofthe time, and the mean ofthe
average difference is-0.6L%.
Figure 8 compares the distribution of0L
(the LAV coefficient of variation) and
Q (the QL coefficient ofvariation). For
both methods, the estimated coefficient of
variation is between 0.25 and 0.40 most of
the time. The median value of L iS 0.321
and the median value of Qis 0.329.
Identification ofBeLPTswith UV SIs
The first step in the alternative method is
to convert each log(SI) into a standardized
deviate (Equation 7) using the values of Uj
and ij given in Table 5. These standardized
deviates are compared with the quantiles of
the standard normal distribution, i.e. Pr[u
< zp] = p. Ifat least two ofthese u,s exceed
zp that BeLPT is called abnormal. The
results (i.e. the u11s for the abnormal
BeLPTs ) ofapplying this procedure to the
173 assays using zO975 = 1.96 are shown in
Table 7. In particular. the standardized
deviates for the LAV log(SI)s for AC147
(Table 6) are given in row 2.
An alternative to calculating standard-
ized deviates for each log(SI) is to calculate
critical value for each SI
SI; = exp(,t7i + zp j), j=1.6.
The critical values obtained usingfj and
for the LAV method in Table 5 are shown
in Table 8. Ifa patient's SI exceeds the cor-
responding critical SI, that SI is considered
large. Thus, ifany two SIs exceed the cor-
responding critical SI, that patient's data
are considered abnormal. For example, the
LAV SIs from Table 6 (patient AC147) are
1.27, 6.36, 4.26, 0.99, 6.11, and 6.11.
C ------------ ---------------
0 , W **
0.2 0.4 0.6 0.8
Figure 8. Comparison of QL and LAV coefficients of
variation (ls).
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Table 7. Values ofthe standardized deviates(u,js) for BeLPTs with at leasttwo >Z0.975.
Day 5 Day 7
Be 1 Be 10 Be 100 Be 1 Be 10 Be 100
ID u u2 U3 U4 U5 U6L
AC128 2.10 0.65 2.11 -1.23 -0.63 0.49 0.30
AC1479 0.61 3.21 1.52 0.33 2.48 1.75 0.26
AC161 u 9.61 6.81 5.95 8.33 5.91 4.74 0.42
AC171 u 2.47 2.53 2.22 1.90 2.45 2.21 0.18
AC174U -0.13 3.22 2.40 -0.50 1.42 1.07 0.27
AC182 0.87 1.20 1.73 3.45 2.17 0.70 0.33
AC187 3.74 1.96 -0.61 1.62 0.07 -0.98 0.71
AC196U 9.08 5.25 2.07 6.50 3.16 2.08 0.38
AC208U 5.76 2.15 0.91 4.38 1.04 0.72 0.42
AC209 3.79 0.96 1.99 2.55 1.82 1.63 0.43
AC218 5.28 -0.07 -0.72 2.75 -1.16 -1.07 0.40
AC225U 4.81 4.75 1.47 4.32 1.73 1.03 0.82
AC235t 5.17 2.23 2.62 2.71 -0.27 1.59 0.39
AC236t 10.04 6.34 3.70 3.15 1.46 0.73 0.21
lDs marked with t were identified as abnormal by the CABST method (Section 3.5) and those marked with uwere
unsatisfactory. One BeLPT (AC149) called abnormal bythe CABST method does not appear in this table.
Table 8. Critical SI values.
Day5 Day7
Be 1 Be 10 Be 100 Be 1 Be 10 Be 100
2.00 3.30 6.00 2.62 3.83 7.72
Since the day 5 Be 10 SI (6.36) and the
day 7 Be 10 SI (6.11) exceed their respec-
tive critical SIs, these data are deemed
abnormal. Regardless of the formulation
used (calculating the standardized deviates
or comparing the SIs to critical SIs) the
conclusion is identical.
The CABST procedure currently used
at ORISE to identify workers with large
SIs is based on the distribution of the
maximum SI for each individual in the
nonexposed group (Equation 6). A BeLPT
for a beryllium worker is defined as abnor-
mal if at least two SIs exceed SI* (currently
equal to 5.65). This leads to the identifica-
tion ofpatients AC147, AC149, AC235,
and AC236 as abnormal. Using the outlier
rejection method, six BeLPTs that had
two or more SIs greater than 5.65 were
found to be unsatisfactory based on the
values of the within-group CVs. They are
patients AC161, AC171, AC174, AC196,
AC208, and AC225. Three of the abnor-
mal BeLPTs are listed in Table 7 (only
AC149 is missing). Table 7 also lists five
BeLPTs as abnormal that were not identi-
fied by the current method as either
abnormal or unsatisfactory.
In situations in which there may be
excess variability, the CV can be used to
evaluate the quality ofthe BeLPT. For the
LAV approach L is a resistant estimate of
the "within-group" standard deviation of
the log well counts. Since L is not inflated
by a few outliers (that could be caused by
measurement error), it may be reflecting
some intrinsic biological variability associ-
ated with the lymphocyte proliferation
response in certain cell donors. Figure 9
shows a normal probability plot for
log(0L). The resistant estimates of the
mean and standard deviation oflog(OL) are
-1.136 and 0.285. From this we compute
the 99th percentile O* = 0.623. The five
BeLPTs in our database that have values
of L > 0.623 are AC242, AC223, AC187,
AC211, and AC225.
Conclusions
Three approaches to the analysis of the
BeLPT have been described. The first
method is the outlier rejection procedure
(in use at ORISE in July 1993), and two
new methods (LAV and QL) are based
on resistant regression techniques. Each
method was applied to a database of 173
BeLPTs (133 from beryllium workers and
40 from individuals with no beryllium
exposure). Graphical and numerical sum-
maries show that the three methods are
generally in very close agreement. Both of
the new methods are highly resistant to
outliers (in the well counts), have well-
known statistical properties, and provide a
"pooled" estimate of the coefficient of
variation (0) for each BeLPT. The QL
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Figure 9. Normal probability plot of log ('L)-
method requires an iterative algorithm and
does not appear to offer any practical
advantage over LAV. The LAV method is
also easy to understand and compute and
is recommended for routine analysis of
the BeLPT.
Estimates of the log(SI)s are approxi-
mately normally distributed. The log(SI)
distributions are centered near zero for
each ofthe three concentrations of BeSO4
on harvest days 5 and 7. The variability
is greater on day 7 than on day 5, and
increases with concentration on each day.
Resistant estimates of the location and
scale parameters for each of the six log(SI)
distributions are used to define large SIs,
which are used to identify abnormal
BeLPTs. Results of this preliminary
approach to identify abnormal BeLPTs
were compared with results obtained using
the current method, and the discrepancies
between the two methods suggest that a
more detailed evaluation of the procedure
is needed.
In a subsequent report further consider-
ation will be given to the use of the LAV
approach to address the following ques-
tions: a) How should "abnormal" BeLPTs
be identified? b) Should a BeLPT be con-
sidered unsatisfactory as the result ofhigh
variability? c) How should the resistant
estimate of the coefficient ofvariation (OL)
be used in the BeLPT analysis?
The methods developed will be
applied to a much larger database of
BeLPTs obtained from the ORISE BeLPT
laboratory and at least one additional labo-
ratory that is currently using this assay to
identify persons who may have CBD. The
data set used in this report and an elec-
tronic version of ORNL-6818 (9) are
available on the world wide web at URL
http://www.epm.ornl.gov/-frome/
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Appendix: Detailed Protocol For BeLPT
The ORISE protocol for performing
lymphocyte proliferation assays essentially
adheres to the recommendations of the
expert panel (i.e., CABST) convened
jointly by the U.S. DOE Office of Health
and the Beryllium Industry Scientific
Advisory Committee (BISAC) at a meeting
held in Washington, DC, on February
3-4, 1992. We collect approximately 30
ml ofvenous whole blood in sterile vacu-
tainers containing sodium heparin for each
assay (Figure 1, text). Tubes are inverted to
mix blood with the anticoagulant and
transported to the laboratory for process-
ing. Cells are maintained at room tempera-
ture overnight. Within 24 hr after blood
collection. mononuclear cells are separated
using Ficoll-hypaque density gradient cen-
trifugation, carried through three sequen-
tial washes and counted in triplicate on an
automated cell counter. Lymphocytes are
cultured in RPMI 1640 culture medium
(GIBCO Grand Island, NY) buffered with
Hepes salts, and supplemented with 2 mM
/-glutamine, 100 units/ml penicillin, and
100 pg/ml streptomycin. Pooled human
serum is added at a final concentration of
10%. We are using 96-well, flat-bottom
microtiter plates and a final cell concentra-
tion of2.5x105 cells per well contained in
0.2 ml volume ofmedium.
Beryllium sulfate ([BeSO4], Brush and
Wellman, Elmore, OH, 99.9% purity) in
concentrations of 1, 10, and 100 pM is
used to evaluate donor lymphocyte hyper-
sensitivity to Be metals. As positive con-
trols we use concanavalin-A (10 pg/ml) and
phytohemagglutinin (30 pg/ml). For each
set of exposures, quadruplicate wells are
evaluated to obtain estimates of lympho-
cyte proliferation response. Unstimulated
control wells are run in replicates of 12
because other laboratories have observed
considerable variability in rates of tritiated
thymidine incorporated in the control
series, and extra replicates are needed to
achieve the required levels ofstatistical con-
fidence. All cells are incubated at 37 +
0.5°C in an atmosphere of 5% CO2 in air.
Cells assayed for response to Be are har-
vested at 5 and 7 days with a terminal 6-8
hr pulse of 1.0 pCi of tritiated thymidine
(specific activity 6.7 mCi/mM). We are
using a Packard 96-well cell harvester
(Packard Instruments, Downer's Grove,
IL) that deposits lymphocytes from each
individual well on a standard glass filter
paper; the lymphocytes then can be
counted intact on the Packard Matrix 96
gas ionization counter, or punched for assay
using a liquid scintillation counter. The
Matrix 96 unit is less efficient in detecting
beta decays than scintillation counters but
has the great advantage ofsimultaneously
detecting beta radiation emissions from all
96 wells. Statistical accuracy can be achieved
quite readily by increasing counting time
using this instrument.
Quality Control
Excess variability in counts between repli-
cate wells within a treatment, i.e., outliers
could result from technical errors in initiat-
ing the tests, or possibly from intrinsic
biological variables associated with the
characteristics of lymphocyte proliferation
response in certain cell donors. Sources of
technical error might include mistakes in
pipetting, such as failures to add appropri-
ate numbers of cells to individual wells,
lack of addition or double addition of
tritiated thymidine to specific wells, or
improper washing of filters resulting in
residual counts of unincorporated thymi-
dine, or smearing of radiolabel across the
filter paper.
Stringent methods for quality control
are used routinely to guard against inadver-
tent technical errors. To minimize the risk
ofpipetting errors, all media and other test
reagents are delivered to complete rows or
columns of the test plate using electronic
micropipetters that deliver up to 8 or 12
aliquots simultaneously. Thus, it is not
likely that the operator could "loose her
place" in adding reagents. Cells are har-
vested onto the surface offilter paper using
the 96-well harvester, which simultaneously
aspirates the cellular contents from each
well. To ensure complete washings of cul-
ture plates, a wash volume of approxi-
mately 10 times that recommended by the
manufacturer is used. For all tests, we rou-
tinely leave all wells in rows A and H
empty as a quality control measure to allow
evaluation ofbackground counts on both
the top and bottom of the filter paper.
Erratic or high counts in these empty wells
would signal incomplete washing ofplates
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Figure Al. ORISE plate maps for BeLPT assay. *Beryllium sulfate 1, 10, 100 pM solutions.
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or "smearing" or radioactivity from one
well to another.
Filter papers are counted intact on the
Matrix 96 gas ionization counter, which
simultaneously records counts and counts-
per-minute with attendant errors for each
well. Because the matrix counter is a gas
ionization unit, only those beta decays that
are emitted at right angles to the surface fil-
ter pad are detected and recorded. Thus,
the sensitivity of the instrument in detect-
ing counts is considerably less than that of
a liquid scintillation counter (about 20%
ofemissions are detected using the gas ion-
ization unit). For this reason, all plates are
counted for longer periods to accumulate
enough counts for statistical accuracy.
Routinely, all plates containing control
wells and wells challenged by beryllium
salts are counted for 30 min, whereas mito-
gen-stimulated positive controls are
counted for 10 min each.
To allow direct comparisons oflympho-
cyte proliferation response between different
blood donors, we routinely initiate 5-day
and 7-day tests on lymphocytes from three
separate donors on a single test plate. The
plate map that is routinely used at ORISE
is shown in Figure Al. Cells from three
persons are cultured on the same microtiter
1 2 3 4 5 6 7 8 9 10 11 12
1-A: 57 47 48 52 126 68 99 69 27 37 36
1-B: 515 881 489 303 191 260 673 382 1300 1451 3353 127
1-C: 535 742 1602 676 310 420 251 669 2850 1368 634 1478
1-0: 923 570 510 568 253 550 333 439 540 1654 1487 1330
1-E: 17700 10749 19080 18855 696 372 270 434 1236 1991 1173 1743
1-F: 19197 27501 27280 31033 286 383 758 1369 1175 1591 1617 1877
1-G: 21083 38090 45938 29685 454 428 366 654 1772 2415 2766 3737
1-H: 41 63 52 75 66 83 91 43 49 44 31 24
Figure A2. Typical printout sheets of data from three individuals.
plate. Cells from patient 1 are pipetted into
columns 1 to 4; cells from patient 2, into
columns 5 to 8; and cells from patient 3,
into columns 9 to 12. Rows A and H are
left blank to monitor background counts in
the culture system. Rows B, C, and D are
replicate sets ofcontrol wells, whereas rows
E, F, and G contain beryllium concentra-
tions of 1, 10, and 100 pM, respectively.
The lower halfof the figure demonstrates
the platemap for initiating cultures with
phytohemagglutinin or ConA.
An example of a typical printout of
data from three different individuals is
shown in Figure A2. The test is a 5-day
plate, counted for 30 min. Data are shown
as total counts. Patient 1 displays a pro-
nounced response to all three levels for
beryllium-challenged wells, whereas patient
3 demonstrates higher levels ofcounts in
control wells but also demonstrates no
response to beryllium. Direct comparisons
of data among the three persons can be
readily made from a single printout sheet.
This approach allows comparisons of
counts within replicate treatments for lym-
phocytes from the same donor, as well as
comparisons of inter-individual variability
in counts between different subjects.
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